AU4849593A - Myocyte-specific transcription enhancing factor 2 - Google Patents

Myocyte-specific transcription enhancing factor 2

Info

Publication number
AU4849593A
AU4849593A AU48495/93A AU4849593A AU4849593A AU 4849593 A AU4849593 A AU 4849593A AU 48495/93 A AU48495/93 A AU 48495/93A AU 4849593 A AU4849593 A AU 4849593A AU 4849593 A AU4849593 A AU 4849593A
Authority
AU
Australia
Prior art keywords
myocyte
specific transcription
enhancing factor
transcription enhancing
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48495/93A
Inventor
Bernardo Nadal-Ginard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Medical Center Corp
Original Assignee
Childrens Medical Center Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center Corp filed Critical Childrens Medical Center Corp
Publication of AU4849593A publication Critical patent/AU4849593A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU48495/93A 1992-09-04 1993-09-07 Myocyte-specific transcription enhancing factor 2 Abandoned AU4849593A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93989892A 1992-09-04 1992-09-04
US939898 1992-09-04
PCT/US1993/008386 WO1994005776A1 (en) 1992-09-04 1993-09-07 Myocyte-specific transcription enhancing factor 2

Publications (1)

Publication Number Publication Date
AU4849593A true AU4849593A (en) 1994-03-29

Family

ID=25473905

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48495/93A Abandoned AU4849593A (en) 1992-09-04 1993-09-07 Myocyte-specific transcription enhancing factor 2

Country Status (2)

Country Link
AU (1) AU4849593A (en)
WO (1) WO1994005776A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025483A (en) * 1996-06-05 2000-02-15 The Regents Of The University Of California Maize and cauliflower apetalai gene products and nucleic acid molecules encoding same
JP2001524801A (en) * 1996-07-09 2001-12-04 ジェネティックス・インスチチュート・インコーポレーテッド Secreted proteins and polynucleotides encoding them
WO1999051983A1 (en) * 1998-04-07 1999-10-14 Regeneron Pharmaceuticals, Inc. Method of identifying agents that block muscle atrophy
WO1999062940A2 (en) * 1998-05-30 1999-12-09 Collateral Therapeutics, Inc. Methods of altering cardiac cell phenotype
WO2000028020A2 (en) * 1998-11-10 2000-05-18 Board Of Regents, The University Of Texas System Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor
FR2797273B1 (en) * 1999-08-06 2004-01-02 Pasteur Institut POLYNUCLEOTIDES DIRECTING ACTIVATION OF GENE EXPRESSION IN THE HEART AND ITS APPLICATIONS TO GENE THERAPY
US6632628B1 (en) 1999-08-20 2003-10-14 Board Of Regents, The University Of Texas System Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression
EP1375663A4 (en) * 2001-03-26 2004-11-24 Takeda Chemical Industries Ltd Novel protein, dna thereof and use of the same

Also Published As

Publication number Publication date
WO1994005776A1 (en) 1994-03-17

Similar Documents

Publication Publication Date Title
AU4166393A (en) Auto-reclosers
AU3490693A (en) Cork
AU3561193A (en) TNF-muteins
AU3991693A (en) Pyrazinoindoles
AU4177593A (en) Benzophenonehydrazones
AU3042892A (en) Rockbolt
AU667580B2 (en) Line-handling block
AU4156393A (en) Heterocyclyltriazolinones
AU3402793A (en) Imidazolyl-substituted phenylacetamides
AU5798394A (en) Thiadiazinones
AU4849593A (en) Myocyte-specific transcription enhancing factor 2
AU664253B2 (en) Photo-deviometer
AU3562193A (en) Morpholin- and thiomorpholin-4-ylamides
AU3461693A (en) Saddle-cloth
AU4164793A (en) Heterocyclyltriazolinones
AU4632493A (en) Weathershed
AU1274295A (en) Heteroarylpyrroles
AU3185693A (en) Pyrrolylbenzodiazepinones
AU4864693A (en) Alkoxymethyl-substituted pyridonebiphenyls
AU5564794A (en) Play-mark
AU4316993A (en) Polyaniles
AU4425593A (en) New isobutyl-substituted methanesulphonyl-quinolylmethoxyphenyl-cycloalkylacetamides
AU4588793A (en) Valve
AU3696093A (en) Aquamate
AU5780894A (en) Crankhead